Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | NCF1 | P14598 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 2/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | HPGD | P15428 | 4/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.32 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13230883 | 0.88 | NCF1 (0.39) | KMT2AMEN1NCF1NPC1RAB9A | |
| SCHEMBL13250585 | 0.87 | NCF1 (0.50) | KMT2ANCF1NPC1RAB9AKDM4E | |
| SCHEMBL13231083 | 0.87 | NCF1 (0.38) | KMT2AMEN1NCF1NPC1RAB9A | |
| SCHEMBL15237215 | 0.86 | NCF1 (0.37) | KMT2AMEN1NCF1NPC1RAB9A | |
| SCHEMBL13230848 | 0.86 | NCF1 (0.39) | KMT2AMEN1NCF1NPC1RAB9A | |
| SCHEMBL13230742 | 0.85 | NCF1 (0.42) | KMT2AMEN1NCF1NPC1RAB9A | |
| SCHEMBL14461150 | 0.83 | MEN1 (0.40) | KMT2AMEN1SOS1DHFRNISCH | |
| SCHEMBL13230948 | 0.83 | NCF1 (0.41) | KMT2AMEN1NCF1NPC1RAB9A | |
| SCHEMBL13230913 | 0.82 | NCF1 (0.38) | KMT2ANCF1NPC1RAB9AKDM4E | |
| SCHEMBL13230796 | 0.82 | MEN1 (0.35) | KMT2AMEN1DHFRNISCHKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100164371-A1 | ELECTRON TRANSPORTING-INJECTION COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LG. DISPLAY CO. LTD. (KR) | 2010-07-01 | — | — | US | disclosed |
| US-20100164371-A1 | ELECTRON TRANSPORTING-INJECTION COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LG. DISPLAY CO. LTD. (KR) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100164371-A1 | ELECTRON TRANSPORTING-INJECTION COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SLCO4C1, SLCO2A1, SLCO2B1 | KMT2A 4439/4885MEN1 1104/4885NCF1 1982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.